| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | tofacitinib | FAERS: 6 | US FAERS | |
| 2 | Lenalidomide | FAERS: 4 | US FAERS | |
| 3 | PCI 32765 | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | palbociclib | FAERS: 3 | US FAERS | |
| 5 | Bosentan | FAERS: 2 | US FAERS | |
| 6 | Dasatinib | FAERS: 2 | US FAERS | |
| 7 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 8 | Glatiramer Acetate | FAERS: 2 | US FAERS | |
| 9 | MDV 3100 | FAERS: 2 | US FAERS | |
| 10 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 11 | Cinacalcet | FAERS: 1 | US FAERS | |
| 12 | Dabigatran | FAERS: 1 | US FAERS | |
| 13 | Exenatide | FAERS: 1 | US FAERS | |
| 14 | LCZ 696 | FAERS: 1 | US FAERS | |
| 15 | Metformin | FAERS: 1 | US FAERS | |
| 16 | Methotrexate | FAERS: 1 | US FAERS | |
| 17 | Naltrexone | FAERS: 1 | US FAERS | |
| 18 | Pregabalin | FAERS: 1 | US FAERS | |
| 19 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 20 | Teriparatide | FAERS: 1 | US FAERS | |
| 21 | ambrisentan | FAERS: 1 | US FAERS | |
| 22 | apremilast | FAERS: 1 | US FAERS | |
| 23 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.